These studies demonstrated that adiponectin concentrations are decreased while leptin levels increased in NAFLD suggesting that a dysbalance of adipokines might promote evolution of this systemic disease. Here, ADIPOQ is linked to metabolic dysfunction-associated steatotic liver disease.